blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3460054

EP3460054 - HISTIDYL-TRNA SYNTHETASE-FC CONJUGATES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.08.2021
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  18.09.2020
FormerGrant of patent is intended
Status updated on  05.05.2020
FormerExamination is in progress
Status updated on  03.12.2019
FormerRequest for examination was made
Status updated on  20.09.2019
FormerThe application has been published
Status updated on  22.02.2019
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
aTyr Pharma, Inc.
3545 John Hopkins Court, Suite 250
San Diego, CA 92121 / US
[2020/22]
Former [2019/13]For all designated states
Atyr Pharma, Inc.
3545 John Hopkins Court, Suite No. 250
San Diego, CA 92121 / US
Inventor(s)01 / Buechler, Ying
1343 Cassins Street
Carlsbad, California 92011 / US
02 / Chiang, Kyle
162 Mystic Street
Arlington, MA 02474 / US
03 / Do, Minh-Ha
3911 Zanako Street
San Diego, California 92122 / US
04 / Lee, Darin
3432 Conrad Avenue
San Diego, California 92117 / US
05 / Piehl, Kristi
5321 Zion Avenue
San Diego, California 92130 / US
06 / Thomas, Marc
800 Orca Avo Drive
Vista, California 92084-0282 / US
07 / Watkins, Jeffry D.
3442 Fortuna Ranch Road
Encinitas, California 92024 / US
08 / Wu, Chi-Fang
2649 Villas Way
San Diego, California 92108 / US
09 / Mendlein, John D.
1550 Neptune Avenue
Encinitas, California 92024 / US
 [2019/24]
Former [2019/13]01 / Buechler, Ying
1343 Cassins Street
Carlsbad, California 92011 / US
02 / Chiang, Kyle
1615 Debann Road
Cardiff, California 92011 / US
03 / Do, Minh-Ha
3911 Zanako Street
San Diego, California 92122 / US
04 / Lee, Darin
3432 Conrad Avenue
San Diego, California 92117 / US
05 / Piehl, Kristi
5321 Zion Avenue
San Diego, California 92130 / US
06 / Thomas, Marc
800 Orca Avo Drive
Vista, California 92084-0282 / US
07 / Watkins, Jeffry D.
3442 Fortuna Ranch Road
Encinitas, California 92024 / US
08 / Wu, Chi-Fang
2649 Villas Way
San Diego, California 92108 / US
09 / Mendlein, John D.
1550 Neptune Avenue
Encinitas, California 92024 / US
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[2019/13]
Application number, filing date18194251.714.03.2014
[2019/13]
Priority number, dateUS201361789011P15.03.2013         Original published format: US 201361789011 P
[2019/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3460054
Date:27.03.2019
Language:EN
[2019/13]
Type: B1 Patent specification 
No.:EP3460054
Date:21.10.2020
Language:EN
[2020/43]
Search report(s)(Supplementary) European search report - dispatched on:EP08.01.2019
ClassificationIPC:C12N9/00, C12N9/96, A61P21/00, A61P29/00, A61P11/00, A61P37/00
[2019/13]
CPC:
C12N9/93 (EP,US); A61P11/00 (EP,US); A61P29/00 (EP,US);
A61P37/00 (EP,US); C12N9/96 (EP,US); C12Y601/01021 (US);
C07K2319/30 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/43]
Former [2019/13]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA17.09.2019
ME17.09.2019
TitleGerman:HISTIDYL-TRNA-SYNTHETASE-FC-KONJUGATE[2019/13]
English:HISTIDYL-TRNA SYNTHETASE-FC CONJUGATES[2019/13]
French:CONJUGUÉS HISTIDYL-ARNT SYNTHÉTASE-RÉGION FC[2019/13]
Examination procedure17.09.2019Amendment by applicant (claims and/or description)
17.09.2019Examination requested  [2019/43]
17.09.2019Date on which the examining division has become responsible
06.12.2019Despatch of a communication from the examining division (Time limit: M02)
23.01.2020Reply to a communication from the examining division
06.05.2020Communication of intention to grant the patent
14.09.2020Fee for grant paid
14.09.2020Fee for publishing/printing paid
14.09.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14727652.1  / EP2970921
Divisional application(s)EP20202708.2   Application withdrawn  : 02.02.2021
Opposition(s)22.07.2021No opposition filed within time limit [2021/39]
Fees paidRenewal fee
13.09.2018Renewal fee patent year 03
13.09.2018Renewal fee patent year 04
13.09.2018Renewal fee patent year 05
27.03.2019Renewal fee patent year 06
27.03.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.03.2014
AL21.10.2020
AT21.10.2020
CY21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
MK21.10.2020
MT21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE14.03.2021
LU14.03.2021
BE31.03.2021
[2024/42]
Former [2024/23]HU14.03.2014
AL21.10.2020
AT21.10.2020
CY21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
MK21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE14.03.2021
LU14.03.2021
BE31.03.2021
Former [2023/33]HU14.03.2014
AL21.10.2020
AT21.10.2020
CY21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE14.03.2021
LU14.03.2021
BE31.03.2021
Former [2023/30]AL21.10.2020
AT21.10.2020
CY21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE14.03.2021
LU14.03.2021
BE31.03.2021
Former [2022/34]AL21.10.2020
AT21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE14.03.2021
LU14.03.2021
BE31.03.2021
Former [2022/23]AL21.10.2020
AT21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE14.03.2021
LU14.03.2021
Former [2022/10]AL21.10.2020
AT21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
PT22.02.2021
IE14.03.2021
LU14.03.2021
Former [2022/09]AL21.10.2020
AT21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE14.03.2021
LU14.03.2021
Former [2022/07]AL21.10.2020
AT21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE14.03.2021
Former [2021/50]AL21.10.2020
AT21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/45]AL21.10.2020
AT21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/36]AT21.10.2020
CZ21.10.2020
EE21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/35]AT21.10.2020
CZ21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/33]AT21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RS21.10.2020
SE21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/32]AT21.10.2020
FI21.10.2020
HR21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RS21.10.2020
SE21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/30]AT21.10.2020
FI21.10.2020
HR21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RS21.10.2020
SE21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/28]AT21.10.2020
FI21.10.2020
HR21.10.2020
LV21.10.2020
PL21.10.2020
RS21.10.2020
SE21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/25]AT21.10.2020
FI21.10.2020
LV21.10.2020
PL21.10.2020
RS21.10.2020
SE21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/24]AT21.10.2020
FI21.10.2020
LV21.10.2020
RS21.10.2020
SE21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
PT22.02.2021
Former [2021/23]FI21.10.2020
LV21.10.2020
RS21.10.2020
SE21.10.2020
NO21.01.2021
GR22.01.2021
PT22.02.2021
Former [2021/22]FI21.10.2020
RS21.10.2020
NO21.01.2021
PT22.02.2021
Former [2021/21]FI21.10.2020
PT22.02.2021
Former [2021/20]FI21.10.2020
Documents cited:Search[I]WO2010107825  (PANGU BIOPHARMA LTD [CN], et al) [I] 1-14 * pages 1-9,32,; claim - * * the whole document *;
 [A]US2011086058  (JIANG SHIBO [US], et al) [A] 1-14 * the whole document *;
 [Y]WO2011072265  (ATYR PHARMA INC [US], et al) [Y] 1-14 * pages 4,37-38; claim -; sequence 28 * * pages 64-65 *;
 [IP]WO2013123432  (ATYR PHARMA INC [US], et al) [IP] 1-14 * the whole document * * pages 87,97; claim - * * page 115 *;
 [YDP]US2014066321  (XU ZHIWEN [CN], et al) [YDP] 1-14 * the whole document *;
 [A]  - PAUL J CARTER, "Introduction to current and future protein therapeutics: A protein engineering perspective", EXPERIMENTAL CELL RESEARCH, ACADEMIC PRESS, US, vol. 317, no. 9, doi:10.1016/J.YEXCR.2011.02.013, ISSN 0014-4827, (20110224), pages 1261 - 1269, (20110301), XP028205664 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.yexcr.2011.02.013
 [A]  - HUANG ET AL, "Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology", CURRENT OPINION IN BIOTECHNOLOGY, LONDON, GB, vol. 20, no. 6, doi:10.1016/J.COPBIO.2009.10.010, ISSN 0958-1669, (20091104), pages 692 - 699, (20091104), XP026778880 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.copbio.2009.10.010
 [A]  - A. HÄUSSERMANN ET AL, "Das Anti-Jo-1-Syndrom - eine Sonderform der Myositis mit interstitieller Lungenerkrankung", PNEUMOLOGIE, (20100412), vol. 64, no. 08, doi:10.1055/s-0029-1244054, ISSN 0934-8387, pages 496 - 503, XP055131699 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1055/s-0029-1244054
 [A]  - LEVINE STUART M ET AL, "Anti-aminoacyl tRNA synthetase immune responses: Insights into the pathogenesis of the idiopathic inflammatory myopathies", CURRENT OPINION IN RHEUMATOLOGY, CURRENT SCIENCE, LONDON, GB, (20031101), vol. 15, no. 6, ISSN 1040-8711, pages 708 - 713, XP009145406 [A] 1-14 * the whole document *
 [A]  - GUZZO ET AL, "Systematic analysis of fusion and affinity tags using human aspartyl-tRNA synthetase expressed in E. coli", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, (20070426), vol. 54, no. 1, doi:10.1016/J.PEP.2007.03.001, ISSN 1046-5928, pages 166 - 175, XP022056649 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.pep.2007.03.001
 [A]  - KATSUMATA ET AL, "Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation", JOURNAL OF AUTOIMMUNITY, LONDON, GB, (20070912), vol. 29, no. 2-3, doi:10.1016/J.JAUT.2007.07.005, ISSN 0896-8411, pages 174 - 186, XP022245362 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jaut.2007.07.005
 [A]  - FRIEDMAN A W ET AL, "Interstitial lung disease with autoantibodies againstaminoacyl-tRNA synthetases in the absence of clinically apparent myositis", SEMINARS IN ARTHRITIS AND RHEUMAT, ELSEVIER, AMSTERDAM, NL, (19960801), vol. 26, no. 1, doi:10.1016/S0049-0172(96)80026-6, ISSN 0049-0172, pages 459 - 467, XP004680757 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0049-0172(96)80026-6
 [T]  - MERTSCHING E C ET AL, "Identification of a T cell immunomodulatory domain in histidyl-tRNA synthetase", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (20180501), Database accession no. EMB-623263267, XP002787016 [T] 1-14 * the whole document *
 [P]  - MERTSCHING E C ET AL, "Identification of a T cell immunomodulatory domain in histidyl-tRNA synthetase", JOURNAL OF IMMUNOLOGY 20180501 AMERICAN ASSOCIATION OF IMMUNOLOGISTS NLD, (20180501), vol. 200, no. 1, Supplement 1, ISSN 1550-6606
 [T]  - Elisabeth Mertsching ET AL, "Identification of a T cell immunomodulatory domain in histidyl-tRNA synthetase", Poster Presentation: Identification of a T Cell Immunomodulatory Domain In Histidyl-Trna Synthetase, New York, (20180502), URL: https://investors.atyrpharma.com/static-files/90075be1-9e21-45f0-a7a4-be03f788c635, (20181203), XP055529376 [T] 1-14 * the whole document *
Examination   - K. Ogilvie ET AL, "ATYR1923 iMod domain of HARS: ATYR1923 Ameliorates Dermal and Pulmonary Fibrosis in a Murine Model of Sclerodermatous Chronic Graft vs. Host Disease Introduction", Poster presented at the Scleroderma Foundation National Patient Education Conference July 27-29, 2018; Philadelphia, PA, (20180727), URL: https://investors.atyrpharma.com/static-files/9ba7f4dd-2956-4a45-ba6b-bbc866cdb690, (20191129), XP055647750
    - Suzanne Paz ET AL, "ATYR1923 Reduces Neutrophil Infiltration in an Acute Lipopolysaccharide (LPS) Lung Injury Model", Keystone Symposia 2019 Conference in Santa Fe, New Mexico from February 24-28, 2019., (20190227), URL: https://www.atyrpharma.com/wp-content/uploads/2019/02/ATYR1923-Reduces-Neutrophil-Infiltration-in-an-Acute-Lipopolysaccharide-LPS-Lung-Injury-Model.pdf, (20191129), XP055647768
by applicantUS3773919
 US4326053
 US4326052
 US4751180
 US4861760
 US4873192
 US4888354
 US4935233
 US5116964
 US5420109
 US5428130
 US5455165
 US5466468
 US5514582
 US5624821
 US5725871
 US5756353
 US5780045
 US5804212
 WO0042072
 US6291212
 US6300099
 US6406697
 US2003190311
 WO2004016750
 WO2005047337
 US2005255144
 US7029872
 US7030226
 US2006173170
 US2006269553
 US2007092940
 US2007092521
 US7217797
 US7230068
 US2007148170
 US2007224188
 US2007253966
 US2007269369
 US7326681
 US2008206246
 US7425619
 WO2008147143
 US2009010921
 US2009017023
 US2009163699
 US7629163
 US7632924
 US7638299
 US7662925
 US2010080794
 US2010092997
 US7700321
 US7732570
 US2010143254
 US7737226
 US7736872
 US2010184959
 US2010203046
 US2010209424
 US2010249382
 US2010255013
 US7816320
 US7820766
 US7829310
 US7838265
 US7883866
 US7939496
 US7947473
 US2011183412
    - DNA Cloning: A Practical Approach, vol. I & II
    - Peptide and protein PEGylation, Advanced Drug Delivery Reviews, (20020000), vol. 54, pages 453 - 609
    - ZALIPSKY, S. et al., "Use of functionalized Poly(Ethylene Glycols) for modification of polypeptides", Polyethylene Glycol Chemistry: Biotechnical and Biomedical Applications
    - DEVERAUX et al., Nucleic Acids Research, (19840000), vol. 12, pages 387 - 395
    - ALTSCHUL et al., Nucl. Acids Res., (19970000), vol. 25, page 3389
    - NEEDLEMAN; WUNSCH, J. Mol. Biol., (19700000), vol. 48, pages 444 - 453
    - E. MEYERS; W. MILLER, Cabios, (19890000), vol. 4, pages 11 - 17
    - ALTSCHUL et al., J. Mol. Biol, (19900000), vol. 215, pages 403 - 10
    - ALTSCHUL et al., Nucleic Acids Res., (19970000), vol. 25, pages 3389 - 3402
    - KUNKEL, Proc. Natl. Acad. Sci. USA., (19850000), vol. 82, pages 488 - 492
    - KUNKEL et al., Methods in Enzymol, (19870000), vol. 154, pages 367 - 382
    - "A model of evolutionary change in proteins). Matrices for determining distance relationships", DAYHOFF et al., Atlas of protein sequence and structure, National Biomedical Research Foundation, (19780000), vol. 5, pages 345 - 358
    - GONNET et al., Science, (19920000), vol. 256, pages 14430 - 1445
    - XU et al., Structure, (20120000), vol. 20, pages 1470 - 7
    - ZAIWARA et al., Mol Biotechnol., (20120000), vol. 51, pages 67 - 102
    - PERONA; HADD, Biochemistry, (20120000), vol. 51, pages 8705 - 29
    - MORIN et al., Trends Biotechol., (20110000), vol. 29, pages 159 - 66
    - COLLINS et al., Annu. Rev. Biophys., (20110000), vol. 40, pages 81 - 98
    - WITTMANN et al., J Vis Exp., (20120000), vol. 65, page e4203
    - FELDMAN et al., Mol Cell, (20120000), vol. 47, pages 585 - 95
    - CLUTTERBUCK et al., J Proteomics, (20110000), vol. 74, pages 704 - 15
    - GIDDINGS; MAITRA, J Biomol Screen, (20100000), vol. 15, pages 1204 - 10
    - WIJNHOVEN et al., Glycoconj J., (20080000), vol. 25, pages 177 - 85
    - FROW et al., Med Res Rev., (20040000), vol. 24, pages 276 - 98
    - ROBERTS; VELLACCIO, The Peptides: Analysis, Synthesis, Biology, Academic Press, Inc., (19830000), vol. 5, page 341
    - Combinatorial Chemistry, John Wiley & Sons Inc., (19970000), page 235
    - Burger's Medicinal Chemistry and Drug Discovery, John Wiley & Sons Inc., (19950000), pages 619 - 620
    - NAKAMURA et al., Nuc. Acid. Res., (20000000), vol. 28, page 292
    - KAMEDA et al., Biochem. Biophys. Res. Commun., (20060000), vol. 349, pages 1269 - 1277
    - ZUKER M., Nucl. Acid Res., (20030000), vol. 31, pages 3406 - 3415
    - MANTYH et al., PNAS, (19950000), vol. 92, pages 2662 - 2666
    - MANTYH et al., Prot. Exp. & Purif., (19950000), vol. 6, page 124
    - MERRIFIELD, J. Am. Chem. Soc., (19630000), vol. 85, pages 2149 - 2154
    - BEAUCAGE et al., Tetrahedron Letters, (19810000), vol. 22, pages 1859 - 1869
    - MATTHES et al., EMBO Journal, (19840000), vol. 3, pages 801 - 805
    - "Structural Genomics Consortium", Nature Methods, (20080000), vol. 5, pages 135 - 146
    - SHIMP et al., Protein Expr Purif., (20060000), vol. 50, pages 58 - 67
    - QING et al., Nature Biotechnology, (20040000), vol. 22, pages 877 - 882
    - GRANT et al., Methods Enzymol., (19870000), vol. 153, pages 516 - 544
    - LI et al., Nature Biotechnology, (20060000), vol. 24, pages 210 - 215
    - HAMILTON et al., Science, (20030000), vol. 301, page 1244
    - HAMILTON et al., Science, (20060000), vol. 313, pages 1441 - 1443
    - WILDT et al., Nature Reviews Microbiol., (20050000), vol. 3, pages 119 - 28
    - GERNGROSS et al., Nature-Biotechnology, (20040000), vol. 22, pages 1409 - 1414
    - TAKAMATSU, EMBO J., (19870000), vol. 6, pages 307 - 311
    - CORUZZI et al., EMBO J., (19840000), vol. 3, pages 1671 - 1680
    - BROGLIE et al., Science, (19840000), vol. 224, pages 838 - 843
    - WINTER et al., Results Probl. Cell Differ., (19910000), vol. 17, pages 85 - 105
    - HOBBS, Yearbook of Science and Technology, McGraw Hill, (19920000), pages 191 - 196
    - ENGELHARD et al., PNAS USA, (19940000), vol. 91, pages 3224 - 3227
    - LOGAN; SHENK, PNAS USA, (19840000), vol. 81, pages 3655 - 3659
    - GRAHAM et al., J. Gen Virol., (19770000), vol. 36, page 59
    - MATHER, Biol. Reprod., (19800000), vol. 23, pages 243 - 251
    - MATHER et al., Annals N.Y. Acad. Sci., (19820000), vol. 383, pages 44 - 68
    - URLAUB et al., PNAS USA, (19800000), vol. 77, page 4216
    - YAZAKI; WU, Methods in Molecular Biology, Humana Press, (20030000), vol. 248, pages 255 - 268
    - SHIN et al., Intern. Rev. Immunol., (19930000), vol. 10, pages 177 - 186
    - UMANA et al., Nat Biotechnol., (19990000), vol. 17, pages 176 - 180
    - DAVIES et al., Biotechnol Bioeng., (20010000), vol. 74, pages 288 - 294
    - SHIELDS et al., J Biol Chem., (20020000), vol. 277, pages 26733 - 26740
    - SHINKAWA et al., J Biol Chem., (20030000), vol. 278, pages 3466 - 3473
    - SHIELDS et al., J Biol Chem., (20010000), vol. 276, pages 6591 - 6604
    - PRESTA et al., Biochem Soc Trans., (20020000), vol. 30, pages 487 - 490
    - ZUCKERMAN et al., CRC Crit Rev Microbiol., (19780000), vol. 7, pages 1 - 26
    - CLYNES et al., PNAS, (19980000), vol. 95, pages 652 - 656
    - GEORGE; HERINGA, J Protein Eng., (20020000), vol. 15, pages 871 - 879
    - MARATEA et al., Gene, (19850000), vol. 40, pages 39 - 46
    - MURPHY et al., PNAS USA, (19860000), vol. 83, pages 8258 - 8262
    - LIU et al., PNAS, (19970000), vol. 94, pages 5525 - 5530
    - KIM et al., PNAS, (19960000), vol. 93, pages 1156 - 1160
    - CHAUDHARY et al., PNAS, (19900000), vol. 87, pages 1066 - 1070
    - BIRD et al., Science, (19880000), vol. 242, pages 423 - 426
    - DESJARLAIS; BERG, PNAS, (19930000), vol. 90, pages 2256 - 2260
    - PNAS, (19940000), vol. 91, pages 11099 - 11103
    - DONNELLY et al., J. Gen. Virol., (20010000), vol. 82, pages 1027 - 1041
    - DONNELLY et al., Journal of General Virology, (20010000), vol. 82, pages 1027 - 1041
    - RYAN et al., J. Gener. Virol., (19970000), vol. 78, pages 699 - 722
    - SCYMCZAK et al., Nature Biotech., (20040000), vol. 5, pages 589 - 594
    - MILLER, LM, Pathology Lecture Notes, Atlantic Veterinary College
    - PUFFENBERGER et al., PLoS ONE, (20120000), vol. 7, no. 1, page e28936
    - PIERCE et al., PNAS USA, (20110000), vol. 108, no. 16, pages 6543 - 6548
    - HOFFMAN AS, Ann. N.Y. Acad. Sci., (20010000), vol. 944, pages 62 - 73
    - Remington's Pharmaceutical Sciences, pages 1035 - 1038,1570-1580
    - FINNIN; MORGAN, J. Pharm. Sci., (19990000), vol. 88, no. 10, pages 955 - 958
    - FICHTNER-FEIGL et al., J. Clin. Invest., (20050000), vol. 115, pages 3057 - 3071
 US20070859203
 US20080128107
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.